Carnitine is essential for muscle energy production and is required fo
r the transport of long chain fatty acids and acyl co-enzyme A derivat
ives across the inner mitochondrial membrane. Recently, an absorptive
transport mechanism was discovered at the small bowel level suggesting
the possibility of a carnitine deficient state in patients with mucos
al damage. Therefore, this study investigated carnitine concentrations
in serum of patients with coeliac disease. Serum samples were obtaine
d from 12 patients with active coeliac disease and seven with non-acti
ve disease, and compared with serum samples of 17 children with gastro
intestinal symptoms but with a small bowel normal on biopsy examinatio
n and 33 normal controls. Total serum carnitine concentration was sign
ificantly lower in the patients with coeliac disease compared with the
other two groups and to reference values. When the degree of atrophy
of coeliac intestinal mucosa was numerically graded, serum carnitine c
oncentrations did not correlate to the degree of the intestinal lesion
but were significantly lower in the damaged intestine compared with t
he group with normal mucosa. It is suggested that coeliac disease shou
ld be considered as a potential cause of secondary carnitine deficienc
y.